Bard Associates Inc. Raises Stock Position in inTEST Co. (NYSE:INTT)

Bard Associates Inc. increased its holdings in inTEST Co. (NYSE:INTT) by 2.1% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 199,170 shares of the company’s stock after buying an additional 4,105 shares during the period. Bard Associates Inc.’s holdings in inTEST were worth $1,454,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of INTT. Ground Swell Capital LLC purchased a new stake in inTEST in the second quarter valued at approximately $112,000. Redwood Wealth Management Group LLC purchased a new position in shares of inTEST in the second quarter valued at $132,000. American Century Companies Inc. purchased a new stake in shares of inTEST during the second quarter worth about $145,000. Allspring Global Investments Holdings LLC raised its position in shares of inTEST by 21.2% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 14,153 shares of the company’s stock valued at $188,000 after purchasing an additional 2,476 shares in the last quarter. Finally, Federated Hermes Inc. bought a new position in inTEST during the 2nd quarter valued at $436,000. Hedge funds and other institutional investors own 63.18% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the stock. Northland Capmk lowered shares of inTEST from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 5th. Northland Securities raised their price target on inTEST from $10.00 to $13.00 and gave the company a “market perform” rating in a report on Monday, November 4th.

Insider Buying and Selling at inTEST

In other news, CEO Richard N. Jr. Grant sold 6,788 shares of inTEST stock in a transaction that occurred on Tuesday, August 27th. The shares were sold at an average price of $6.97, for a total transaction of $47,312.36. Following the completion of the sale, the chief executive officer now owns 164,929 shares in the company, valued at $1,149,555.13. The trade was a 3.95 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 5.50% of the company’s stock.

inTEST Trading Down 2.5 %

NYSE:INTT opened at $7.41 on Friday. The company has a market capitalization of $91.74 million, a P/E ratio of 17.27 and a beta of 1.92. The stock’s 50 day moving average price is $7.14 and its 200 day moving average price is $8.64. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.38 and a current ratio of 2.26. inTEST Co. has a 52 week low of $6.28 and a 52 week high of $14.35.

inTEST (NYSE:INTT) last announced its earnings results on Friday, November 1st. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.07 by $0.03. inTEST had a net margin of 2.33% and a return on equity of 5.31%. The business had revenue of $30.27 million for the quarter, compared to analyst estimates of $32.97 million. On average, research analysts forecast that inTEST Co. will post 0.41 EPS for the current fiscal year.

inTEST Profile

inTEST Corporation provides test and process technology solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies.